Tesla sales fell by 9 percent in 2025, its second yearly decline

Tesla reported steep declines in production and deliveries, with Q4 sales down nearly 16% year-over-year (a shortfall of 77,343 vehicles) and full-year 2025 deliveries falling 8.6% to 1,636,129 units (153,097 fewer than 2024). The company remains heavily dependent on the Model 3/Y lineup, faces a failed Cybertruck rollout and a cancelled in-house cell program, and its South Korean battery-material supplier L&F took a >99% write-down on a $2.9bn contract to $7,386—evidence of collapsing demand. Management and brand issues, including CEO controversy that may be depressing demand in key markets such as California and Europe, further risk revenue and margin pressure going forward.

Analysis

Market structure: Tesla’s 16% q/q and ~8.6% y/y sales decline redistributes demand to incumbent OEMs and low-cost Chinese competitors (e.g., BYD/1211.HK, BYDDY). Battery-material suppliers and utility-scale storage hopefuls face immediate demand contraction — expect downward pressure on lithium and nickel prices and margin compression for cell suppliers (L&F-style write-downs). Equity volatility for TSLA should spike near-term (implied vol +20–40%), while credit spreads for non-investment-grade auto suppliers could widen 100–300 bps.

Risk assessment: Tail risks include a governance-driven consumer boycott, accelerated price wars (margin squeeze), or a major supplier bankruptcy leading to production disruption; each could cause >30% TSLA share moves. Timeline: immediate (days) = IV spike and sell-side repricing; short-term (6–12 weeks) = promotional pricing and inventory destocking; long-term (6–24 months) = structural market-share loss to lower-cost/global platforms. Hidden dependencies: FSD/software revenue and Supercharger network monetize customer base — deterioration here amplifies earnings risk.

Trade implications: Favor tactical downside on TSLA using limited-risk option structures; prefer relative plays long low-cost Chinese OEMs and selective legacy OEMs with scale (BYDDY, VWAGY) while reducing exposure to lithium miners if spot falls >20%. Entry: implement trades within 3–7 trading days; reassess before Tesla’s next quarterly release (~6–8 weeks). Exit/size: keep TSLA exposure ≤2% portfolio per trade, target 20–35% downside within 3 months.

Contrarian angles: Consensus overlooks Tesla’s service/software moat and China manufacturing leverage — downside could be overdone if management cuts prices to regain share or pivots capex to buybacks. Historical parallels (Nokia handset decline vs Microsoft/Apple pivots) show severe drawdowns can reverse with disciplined execution. Risk: short TSLA can be violently squeezed by retail/option gamma; size accordingly and prefer defined-risk spreads.

Key Decisions for Investors

• Establish a defined-risk short on TSLA sized to 1–2% of portfolio: buy a 3-month put spread targeting ~25–35% downside (buy 30% OTM put, sell 15% OTM put as reference), enter within 3–7 trading days, take profit at 20–30% realized drop or cut loss at 15% premium erosion.
• Initiate a 2–3% long position in BYD (BYDDY or 1211.HK) for 6–12 months to capture share gains in China; set a price target +25% and stop-loss at -12% from entry due to geopolitical/FX risk.
• Reduce exposure to lithium/minerals miners (e.g., ALB, LAC) by 50% or establish a 1% portfolio short if spot lithium price falls >20% from current levels; horizon 3–6 months, as inventory destocking will pressure near-term pricing.
• Implement a volatility play: buy 1–2% notional of TSLA 1-month ATM straddles only if IV spikes >40% (expectation: continued headline-driven moves), and unwind within 10 trading days or prior to next earnings to capture event-driven premium.
• Monitor three concrete catalysts over next 30–60 days before re-levering: (1) Tesla quarterly sales/price cuts, (2) formal Cybertruck program update or cancellation, (3) battery-supplier impairment announcements (L&F-style) — any one increases conviction to widen position.